Discontinued — last reported Q3 '25
ResMed Income and Other Taxes decreased by 51.4% to $71.67M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 370.3%, from -$26.52M to $71.67M. Over 4 years (FY 2021 to FY 2025), Income and Other Taxes shows relatively stable performance with a -0.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
High cash tax payments relative to income tax expense may indicate timing differences or deferred tax settlements, while low payments may suggest tax planning efficiency.
The total cash outflow related to income taxes and other tax-related obligations during the period. This metric reflects...
Highly dependent on the geographic mix of earnings and the effective tax rate of the company's operating jurisdictions.
unp_income_and_other_taxes_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $41.05M | $345.91M | $36.99M | $49.37M | $45.85M | $53.44M | $54.55M | $37.58M | $71.30M | $76.75M | $96.69M | $61.81M | $43.16M | $105.70M | $118.65M | -$26.52M | $16.18M | $61.87M | $147.55M | $71.67M |
| QoQ Change | — | +742.6% | -89.3% | +33.4% | -7.1% | +16.5% | +2.1% | -31.1% | +89.7% | +7.6% | +26.0% | -36.1% | -30.2% | +144.9% | +12.2% | -122.3% | +161.0% | +282.5% | +138.5% | -51.4% |
| YoY Change | — | — | — | — | +11.7% | -84.6% | +47.5% | -23.9% | +55.5% | +43.6% | +77.3% | +64.5% | -39.5% | +37.7% | +22.7% | -142.9% | -62.5% | -41.5% | +24.4% | +370.3% |